Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Takeda Pharmaceutical Co ( (JP:4502) ) has provided an announcement.
Takeda Pharmaceutical Co announced the disposal of 17,355,770 treasury shares under its Long-Term Incentive Plan (LTIP) for employees outside Japan, valued at 75.25 billion yen. This initiative aims to align employee interests with shareholders, attract and retain talent, and balance risk and reward, potentially enhancing the company’s competitive positioning and operational efficiency.
The most recent analyst rating on (JP:4502) stock is a Buy with a Yen5500.00 price target. To see the full list of analyst forecasts on Takeda Pharmaceutical Co stock, see the JP:4502 Stock Forecast page.
More about Takeda Pharmaceutical Co
Takeda Pharmaceutical Co is a global pharmaceutical company based in Osaka, Japan, and Cambridge, Massachusetts. It focuses on providing innovative medicines and therapies, primarily in the fields of oncology, gastroenterology, neuroscience, and rare diseases.
Average Trading Volume: 5,044,042
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen6807.4B
See more data about 4502 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue